The 2013 Third Quarterly Report of Livzon Pharmaceutical Group Inc.
The 2013 Third Quarterly Report of Livzon
Pharmaceutical Group Inc.
Announcement No.: 2013-54
October 2013
The 2013 Third Quarterly Report of Livzon Pharmaceutical Group Inc.
Section I Important Notice
The Board of Directors (BOD), Board of Supervisors (BOS), directors, supervisors, and senior executives hereby
guarantee that the data in the present report contain no false representation, misleading statements and serious
omissions, and shall be severally and jointly liable for the authenticity, accuracy and completeness of the content.
All directors attended the shareholders’ meeting examining this quarterly report.
Mr. Zhu Baoguo, principal of the Company, Mr. An Ning, the principal in charge of accounting, and Ms. Si Yanxia, the
principal of the Accounting Department hereby declare: We guarantee the authenticity, accuracy and completeness of
the Financial Report in this quarterly report.
This third quarterlyl report is issued in Chinese and English versions. In case that there is any ambiguity in the
interpretation of two versions, the Chinese version will prevail.
The 2013 Third Quarterly Report of Livzon Pharmaceutical Group Inc.
Section II Financial highlights and Shareholder Changes
I. Financial highlights
Are there any retrospective adjustments or restatement of accounting data for previous reporting years due to the
changes of accounting policies?
□ Yes √ No
Increase or decrease
End of this report period End of previous year compared with end of
previous year (%)
Total assets (RMB Yuan) 6,508,786,889.25 5,633,753,961.14 15.53%
Net asset attributable to the
shareholders of listed company 3,237,077,032.09 3,008,015,808.63 7.62%
(RMB Yuan)
Increase or decrease Increase or
compared with same Year beginning to decrease compared
This report period
period of previous end of report period with same period of
year (%) previous year (%)
Total operating income(RMB Yuan) 1,071,097,691.06 4.60% 3,233,359,513.46 11.15%
Net profit attributable to
shareholders of listed 119,424,573.63 3.91% 378,734,988.27 10.22%
company(RMB Yuan)
Net profit attributable to
shareholders of listed company
113,996,740.15 2.77% 362,377,911.49 10.28%
after deduction of non-recurring
profit and loss (RMB Yuan)
Net cash flows from operating
-- -- 352,630,802.56 -33.37%
activities (RMB Yuan)
Basic profit per share (RMB
0.40 2.56% 1.28 10.34%
Yuan/share)
Diluted profit per share (RMB
0.40 2.56% 1.28 10.34%
Yuan/share)
Weighed yield rate of net asset Down0.17 Up 0.10 percentage
3.76% 12.03%
（%） percentage points points
The items and amounts of non-recurring profit and loss
√ Applicable □ Not applicable.
Unit: (RMB) Yuan
Item Amount from the year Note
The 2013 Third Quarterly Report of Livzon Pharmaceutical Group Inc.
beginning to end of report
period
Profit and loss in disposal of non-current assets (including the
-333,171.11
written-off part of already withdrawn depreciation reserves)
Governmental allowance accrued to the current profit and loss,
except those that are closely related to the normal operation
businesses of company, and are continuously granted based on 28,172,403.96
the certain standard quota or certain quantity in accordance with
the uniform national standards
Except the effective hedge business related to the normal
operation business of the company, the profit and loss in the Profit and loss from the
changes of fair values caused by the holding of tradable financial changes of fair values
-1,788,681.11
assets and tradable financial liabilities as well as the investment caused by the tradable
returns in disposal of tradable financial assets, tradable financial financial assets.
liabilities and saleable financial assets
Other net non-operating income and payment except the above
1,050,343.30
items
Minus: effect of income tax 5,621,453.27
Effect of the minority of shareholders’ equities (after the taxation) 5,122,364.99
Total 16,357,076.78 --
For the non-recurring profit and loss items that the company has defined in accordance the No. 1 Explanatory
Announcement about Information Disclosure of Companies Making Public Offering of Securities – Non-recurring Profit
and Loss as well as the non-recurring profit and loss items listed by the No. 1 Explanatory Announcement about
Information Disclosure of Companies Making Public Offering of Securities – Non-recurring Profit and Loss that are defined
as the recurring profit and loss items by, please specify the reasons:
□ Applicable √ Not applicable.
II. Table about total quantity of all shareholders and shareholding particulars of top
ten shareholders at the end of report period
Unit: share
Total quantity of shareholders at
The shareholder quantity amounted to 17,940 (including 6,038 B-share holders)
the end of report period
Shares held by top ten shareholders
Quantity of Shares for the
Shareholding
Shareholder Quantity of shares with mortgage or freezing
Shareholder name percentage
nature shares trading Share
(%) Quantity
restriction status
Joincare Pharmaceutical Group Domestic
26.21% 77,510,167
Industry Co., Ltd non-state-owned
The 2013 Third Quarterly Report of Livzon Pharmaceutical Group Inc.
legal person
TOP SINO INDUSTRIES Foreign legal
17.13% 50,660,052 50,660,052
LIMITED SHENZHEN A/C person
Foreign legal
GAOLING FUND,L.P. 3.64% 10,767,777 10,767,777
person
First Shanghai Securities Co., Foreign legal
3.53% 10,444,157 10,106,560
Ltd person
Industrial and Commercial Bank
of China- Bosera Finely-selected
Others 2.96% 8,748,287
Stock Securities Investment
Fund
Mortgage
Guangzhou Begol Trading State-owned
2.05% 6,059,428 6,059,428 and 6,059,428
Corporation legal person
freezing
Domestic
Shenzhen Haibin
non-state-owned 1.99% 5,892,943
Pharmaceutical Co., Ltd
legal person
Agricultural Bank of China-
Greatwall Anxin Return Mixed Others 1.86% 5,500,000
Securities Investment Fund
Bank of Communications -
Bosera New Growth Stock-type Others 1.85% 5,464,326
Securities Investment Fund
Industrial and Commercial Bank
of China- E-fund Value Growth Others 1.83% 5,400,000
Mix Securities Investment Fund
Shareholding particulars of top ten shareholders without trading restriction
Quantity of shares without Share type
Shareholder name
trading restriction Share type Quantity
RMB common
Joincare Pharmaceutical Group Industry Co., Ltd 77,510,167 77,510,167
share
Industrial and Commercial Bank of China- Bosera RMB common
8,748,287 8,748,287
Finely-selected Stock Securities Investment Fund share
RMB common
Shenzhen Haibin Pharmaceutical Co., Ltd 5,892,943 5,892,943
share
Agricultural Bank of China- Greatwall Anxin Return RMB common
5,500,000 5,500,000
Mixed Securities Investment Fund share
Bank of Communications - Bosera New Growth RMB common
5,464,326 5,464,326
Stock-type Securities Investment Fund share
Industrial and Commercial Bank of China- E-fund 5,400,000 RMB common 5,400,000
The 2013 Third Quarterly Report of Livzon Pharmaceutical Group Inc.
Value Growth Mix Securities Investment Fund share
Agricultural Bank of China – Penghua power growth RMB common
3,800,000 3,800,000
mixed securities investment funds share
Industrial and Commercial Bank of China- Harvest RMB common
3,796,891 3,796,891
Strategic Growth Mixed Securities Investment Fund share
RMB common
Columbia University 3,317,433 3,317,433
share
China Construction Bank – Greatwall Consumption RMB common
2,878,296 2,878,296
Value-added Stock-type Securities Investment Fund share
①On January 2, 2004, Joincare Pharmaceutical Group Industry
Co., Ltd (hereinafter called as the “Joincare”), Guangzhou Begol
Trading Corporation (hereinafter called as the “Begol”) and Zhuhai
Lishi Investment Co., Ltd signed the Agreement on Equity
Transfer, Custody and Mortgage. Joincare and Guangzhou Begol
Trading Corporation signed the Agreement on Equity Transfer and
Custody and the Agreement on Equity Mortgage, in which
Guangzhou Begol Trading Corporation directly transferred,
custodized and mortgaged 6,059,428 domestic legal person
shares of our company to Joincare; ② the above TOP SINO
INDUSTRIES LIMITED SHENZHEN A/C and Shenzhen Haibin
Pharmaceutical Co., Ltd are the subcompanies directly or
indirectly held 100% by Joincare; ③ the managers of Industrial
Description of relationship or concerted action and Commercial Bank of China- Bosera Finely-selected Stock
between above shareholders: Securities Investment Fund and Bank of Communications -
Bosera New Growth Stock-type Securities Investment Fund are
Greatwall Fund Management Co., Ltd; ④the managers of
Agricultural Bank of China- Greatwall Anxin Return Mixed
Securities Investment Fund and China Construction Bank –
Greatwall Consumption Value-added Stock-type Securities
Investment Fund are Harvest Fund Management Co., Ltd; except
the above information, the Company does not know whether there
are other relations between the top ten shareholders, or between
top ten tradable shareholders without trading restriction, or top ten
tradable shareholders without trading restriction and top ten
shareholders or whether they belong to the persons acting in
concert stated in the Management Measures about Takeover of
Listed Companies.
Note: TOP SINO INDUSTRIES LIMITED SHENZHEN A/C is the English name of Tiancheng Industry Co., Ltd.
Have the company shareholders reached an agreement about repurchase transaction during the report period?
□ Yes √ No
The 2013 Third Quarterly Report of Livzon Pharmaceutical Group Inc.
Section III Major Events
I. Great changes and reasons of main financial statement items and financial indexes
of the Company
Unit: (RMB) Yuan
Increase
Items in the Balance September 30, December 31, or
Reasons for changes
Sheet 2013 2012 decrease
(%)
Tradable financial The main cause is the sales of part of
9,164,160.31 59,319,616.94 -84.55%
assets tradable financial assets.
The main cause is the increase of
Notes receivable 181,942,920.98 112,482,782.18 61.75% settlement of sales volume by the bank
acceptance bills.
The main cause is the increase of
investments in Ningxia Livzon Industry
Engineering under
1,636,265,970.55 1,028,769,050.48 59.05% Park project and the relocation project
construction
